سعر كا أترا 10 مجم 2026

• Induction of remission in patients with acute promyelocytic leukemia (APL) characterized by t(15;17) translocation and/or PML/RARα presence (see full label for eligibility and combination therapy).DailyMed (FDA), FDA / Accessdata label (Vesanoid class oral tretinoin)

• Oral tretinoin for APL carries risks including differentiation syndrome (RA-APL syndrome), leukocytosis, and teratogenicity — specialist oncology supervision required; see boxed warnings on US labels.International label, same formulation · DailyMed (FDA), FDA / Accessdata label (Vesanoid class oral tretinoin)

• Oral tretinoin is teratogenic; contraindicated in pregnancy unless life-threatening APL and no safer alternative — specialist protocols apply.International label, same formulation · DailyMed (FDA), FDA / Accessdata label (Vesanoid class oral tretinoin)

English text not available for this section.